Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenue, net $ 8,440 $ 8,433 $ 16,639 $ 16,003
Cost of revenue 5,029 4,791 9,946 8,952
Gross profit 3,411 3,642 6,693 7,051
Operating expenses        
Selling, general and administrative 8,081 6,766 16,562 12,911
Research and development 2,478 2,355 5,004 4,420
Total operating expenses 10,559 9,121 21,566 17,331
Loss from operations (7,148) (5,479) (14,873) (10,280)
Other income (expense)        
Interest income 347 1 666 2
Interest expense (31) 0 (52) 0
Other income 84 38 198 39
Loss on disposal of assets (13) 0 (85) 0
Change in fair value of warrant liabilities 0 765 0 1,527
Total other income (expense), net 387 804 727 1,568
Loss before income tax expense (6,761) (4,675) (14,146) (8,712)
Income tax expense (benefit) 20 (1) 38 (1)
Net loss $ (6,781) $ (4,674) $ (14,184) $ (8,711)
Net loss per share:        
Basic (in dollars per shares) [1] $ (0.99) $ (0.70) $ (2.10) $ (1.32)
Diluted (in dollars per shares) [1] $ (0.99) $ (0.70) $ (2.10) $ (1.32)
Weighted average common shares outstanding:        
Basic (in shares) [1] 6,835,568 6,633,658 6,756,394 6,615,649
Diluted (in shares) [1] 6,835,568 6,633,658 6,756,394 6,615,649
Other comprehensive income (loss)        
Foreign currency translation adjustment $ 5 $ (174) $ 44 $ (226)
Comprehensive loss $ (6,776) $ (4,848) $ (14,140) $ (8,937)
[1] Retroactively adjusted shares issued and outstanding, and per share information to give effect to the Company's 1-for-8 reverse stock split. See Note 2.